Search results for

Call it fate or an unfortunate coincidence that Dr. Seuss' eco-parable marks its 50th anniversary just as the United Nations releases a report on the dire consequences of human-induced climate change.

Here's how their hospitals are doing nearly two years into the pandemic, what they are seeing in new omicron patients, and their thoughts on the wave of burnout affecting the industry.

Ayesha Roscoe speaks with Tabbatha Plomaritus, a single parent from Ann Arbor, Mich., about juggling remote learning and work.

When COVID-19 symptoms linger for weeks, but not long enough to become long COVID, it's confusing and scary for patients. Doctors say this is common. Should we start talking about medium COVID?

NPR's A Martinez speaks to the David Nabarro, a special envoy for the World Health Organization, about the direction the pandemic might take in 2022.

Scientists may not know for a couple weeks yet how risky the new coronavirus variant will be to public health. But getting out front now about what is known helps dispel misinformation, they say.

NPR's Rachel Martin speaks with Neel Kashkari, president and CEO of the Federal Reserve Bank of Minneapolis, about the U.S. economy, inflation concerns and interest rates.

So far the government has distributed nearly 400,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.

Omicron may cause milder disease, but the sheer number of patients makes this wave far worse for the health care system. With packed emergency rooms, patients can wait days to get moved to a bed.

The omicron variant is outpacing the government's ability to make and execute clear pandemic public policy.